Apogee Therapeutics, Inc. · NASDAQ:APGE

T. Rowe Price Investment Management, Inc. reported a 11.30% stake in Apogee Therapeutics, Inc. (Schedule 13G)

Event Feb 28, 2026 · Filed Mar 6, 2026

T. Rowe Price Investment Management, Inc. reported a 11.30% stake in Apogee Therapeutics, Inc., 6,213,827 shares, as a passive investor on Feb 28, 2026. Filed Mar 6, 2026 (Schedule 13G).

Stake
11.30%
Shares
6,213,827
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
T. Rowe Price Investment Management, Inc.11.30%6,213,827

Source

View original at SEC

Related